NOC vs OGN · P/E 17, rev $20.76B vs P/E 3.4, rev $3.02B
Northrop Grumman Corporation (NOC) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the NOC and OGN stock pages for the full models.
Not investment advice.